Wire Stories
794Intralink-Spine, Inc. Adds Clinical Sites in Australia
LEXINGTON, Ky.–(BUSINESS WIRE)–Intralink-Spine, Inc. (ILS) announces the expansion of clinical trials for their patented injectable medical device, Réjuve ®, intended in Australia...
- 986
Wipro Limited Announces Results for the Quarter Ended June 30, 2020 Under IFRS
IT Services Operating Margin3 for the quarter was at 19.0% Earnings Per Share up by 5.7% YoY BANGALORE, India & EAST BRUNSWICK,...
- 808
PUBG Celebrates 70 Million Units Sold With the Newly Remastered Sanhok Map for Season 8
Update 8.1 welcomes players back to the jungle with a reimagined map, the Loot Truck, a new Ranked Mode season, and more...
- 826
PFU, a Fujitsu Company, Joins Qualcomm Smart Cities Accelerator Program and Collaborates with Innominds on Contactless Facial Biometric Technologies
YOKOHAMA, Japan & SUNNYVALE, Calif.–(BUSINESS WIRE)–#2dsensor–PFU Limited, a Fujitsu company, announced today that it has joined the Qualcomm® Smart Cities Accelerator Program...
- 883
Wipro to Acquire IVIA Serviços de Informática Ltda, a Specialized IT Services Provider to Financial Services, Retail and Manufacturing Sectors in Brazil
BANGALORE, India & FORTALEZA, Brazil–(BUSINESS WIRE)–#AlexandreMenezes–Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process...
- 772
HD Medical Awarded FDA Clearance For HD Steth
Intelligent Stethoscope with Integrated ECG delivers Instant Cardiac Insights SANTA CLARA, Calif.–(BUSINESS WIRE)–#FDAClearance—HD Medical, Inc. of Silicon Valley today announces that its...
- 847
Mary Kay Celebrates 10-year Anniversary of Women’s Empowerment Principles With a Continued Commitment to Women’s Leadership and Inclusion
DALLAS–(BUSINESS WIRE)–According to World Economic Forum, at the current rate, it will take 140 years to achieve gender equality in top leadership...
- 798
Deciphera Announces Australian Therapeutic Goods Administration’s Approval of QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
– QINLOCK is the First Approved Tyrosine Kinase Inhibitor Designed Specifically for GIST Regardless of Patients’ Mutational Status – – QINLOCK Approved...
- 808
Xylem updates second quarter results, announces major contract wins
Solid performance in context of COVID-19 market challenges Healthy longer-term commercial momentum with large, signature project wins Company to report second quarter...
- 767
Khawaja Holdings Plans Expansion into United States Market
NEW DELHI, India–(BUSINESS WIRE)–#ahmadkhawaja—Khawaja Holdings, a multinational holding company, announces new plans to expand into the United States. Khawaja Holdings, led by...
